Sana Biotechnology earnings were -$208.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SANA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$49.4M, up 0.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SANA reported annual earnings of -$266.8M, with -5.8% growth.
What were Sana Biotechnology's earnings last quarter?
On SANA's earnings call on Invalid Date, Sana Biotechnology (NASDAQ: SANA) reported Q1 2025 earnings per share (EPS) of -$0.21, up 57.14% year over year. Total SANA earnings for the quarter were -$49.39 million. In the same quarter last year, Sana Biotechnology's earnings per share (EPS) was -$0.49.
As of the last Sana Biotechnology earnings report, Sana Biotechnology is currently losing money. Sana Biotechnology's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$208.67 million, a 32.38% decrease year over year.
What was SANA's earnings growth in the past year?
As of Sana Biotechnology's earnings date in Invalid Date, Sana Biotechnology's earnings has grown year over year. SANA earnings in the past year totalled -$208.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.